Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
FDA Outlines Future Tech Priorities
FDA is advancing its tech capabilities with quantum computing, zero-trust architecture and modernized data sharing.
6m read -
GenAI Remains Top Focus for Public Sector IT Leaders
Federal leaders say generative AI is showing promise for efficiency in multiple use cases and sectors, including cancer research.
5m read -
This Partnership is Tackling Federal Zero Trust, Cloud Security
Industry leaders share insights on the critical role industry partnerships have in enabling government agencies to navigate procurement challenges for cloud and zero trust solutions.
16m watch Partner Content -
GenAI Automates Space Force Data Discovery
Space Force’s Will Haskell discusses GenAI advancements that are streamlining data access and analysis and enhancing workflows.
2m read
